Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASI trial of simplified once-daily mesalazine adherence in ulcerative colitis
2019-002070-31Phase 4Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Salcrozine in autoimmune colitis (2 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Drug accountability at least 80%. Started Jun 2019; status: completed.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2019-002070-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002070-31.